epigallocatechin gallate has been researched along with Carcinoma, Anaplastic in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 14 (46.67) | 29.6817 |
| 2010's | 15 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, I; Correia-Branco, A; Costa, T; Faria, A; Keating, E; Martel, F; Moreira, L | 1 |
| Chang, Z; Fan, Q; Wang, F; Wang, L | 1 |
| Chao, LK; Chen, YJ; Hung, PH; Lin, CH | 1 |
| He, X; Huang, L; Li, Z; Wang, W; Xuan, G; Yi, S; Zhang, W | 1 |
| Chang, Y; Chen, CL; Chen, JY; Chuang, HY; Fang, CY; Hsu, HY; Huang, SY; Tsai, CH; Tsao, GS; Wu, CC | 1 |
| Chen, YC; Gao, Y; Rankin, GO; Tu, Y | 1 |
| He, ZW; Huang, GL; Kong, X; Li, BB; Li, HH | 1 |
| Esselen, M; Fridrich, D; Marko, D; Pahlke, G; Teller, N | 1 |
| Katiyar, SK; Punathil, T; Tollefsbol, TO | 1 |
| Adachi, S; Hata, K; Hirose, Y; Moriwaki, H; Sakai, H; Shimizu, M; Shirakami, Y; Tanaka, T; Tsurumi, H | 1 |
| Chan, TH; Chen, D; Dou, QP; Landis-Piwowar, K | 1 |
| Amatangelo, MD; Goodyear, SM; Sell, C; Stearns, ME; Varma, D | 1 |
| Coelho, MA; Generalov, R; Juzenas, P; Pereira, Mdo C; Peres, I; Rocha, S | 1 |
| Cha, YY; Lim, YC | 1 |
| Liu, Z; Wang, F; Wang, Y; Zhao, Q; Zhu, Z | 1 |
| Kostin, SF; McDonald, DE; McFadden, DW | 1 |
| Chen, YJ; Hung, PH; Lin, CH; Shen, YA; Yu, YB | 1 |
| Fan, C; Kong, Z; Lei, X; Liu, Q; Xiang, Q; Yi, S | 1 |
| Kamigaki, T; Koizumi, T; Kuroda, Y; Nakamura, Y; Suzuki, Y; Takada, M; Takeyama, Y; Toyama, H | 1 |
| Gupta, S; Hussain, T; Mukhtar, H | 1 |
| Ahn, WS; Bae, SM; Huh, SW; Kim, CK; Lee, IP; Lee, JM; Namkoong, SE; Sin, JI | 1 |
| Lim, JT; Masuda, M; Suzui, M; Weinstein, IB | 1 |
| Borska, S; Drag-Zalesińska, M; Gebarowska, E; Wysocka, T; Zabel, M | 1 |
| Belluco, C; Dell'Aica, I; Dittadi, R; Garbisa, S; Gion, M; Lise, M; Pezzato, E; Sartor, L | 1 |
| Le, AD; Lu, Q; Rao, J; Tang, X; Zhang, Q; Zhang, Z | 1 |
| Blumberg, JB; Boucher, Y; Eisenberg, DM; Held, KD; Jain, RK; Kashiwagi, S; Lawenda, BD; Loeffler, JS; Niemierko, A; Silverstein, JR; Smith, DE; Xu, L | 1 |
| Cai, SR; He, YL; Li, ZR; Ma, JP; Peng, JS; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH | 1 |
| Adhami, VM; Asim, M; Hafeez, BB; Malik, A; Mukhtar, H; Sarfaraz, S; Siddiqui, IA | 1 |
| Hara, Y; Imazawa, H; Isemura, M; Mita, T; Sazuka, M; Shoji, Y | 1 |
| Belfi, CA; Berger, SJ; Gosky, DM; Gupta, S; Mukhtar, H | 1 |
30 other study(ies) available for epigallocatechin gallate and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Catechin; Cell Death; Cell Proliferation; Female; Glucose; Humans; Lactic Acid; MCF-7 Cells; Quercetin; Receptors, Estrogen | 2013 |
Epigallocatechin‑3‑gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase‑2.
Topics: Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Activation; Female; Humans; Imidazoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Biosynthesis; Pyridines | 2014 |
EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; Signal Transduction; Spheroids, Cellular; STAT3 Transcription Factor; Time Factors | 2014 |
[Signifinace of cyclin D1 expression in CNE2 cells processed by EGCG].
Topics: Carcinoma; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2014 |
EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.
Topics: Animals; Apoptosis; Cadherins; Carcinoma; Caspase 3; Catechin; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Gelatinases; Humans; Mice; Mice, SCID; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; NF-kappa B; Signal Transduction; Spheroids, Cellular; Transplantation, Heterologous; Up-Regulation | 2015 |
Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.
Topics: Biflavonoids; Carcinoma; Catechin; Cell Line, Tumor; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinase Kinases; Neovascularization, Pathologic; Oncogene Protein v-akt; Ovarian Neoplasms; Proto-Oncogene Proteins c-myc; Receptor, Notch1; Signal Transduction; Vascular Endothelial Growth Factor A | 2016 |
Epigallocatechin-3-gallate Modulates MicroRNA Expression Profiles in Human Nasopharyngeal Carcinoma CNE2 Cells.
Topics: Antineoplastic Agents; Carcinoma; Catechin; Cell Line, Tumor; Computational Biology; Gene Expression; Humans; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Real-Time Polymerase Chain Reaction; Signal Transduction | 2017 |
Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation.
Topics: Anthocyanins; Carcinoma; Catechin; Cell Line, Tumor; ErbB Receptors; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Quercetin; Receptor, ErbB-2; Vulvar Neoplasms | 2008 |
EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase.
Topics: Animals; Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Mammary Neoplasms, Animal; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitrogen Oxides; Oxadiazoles; Quinoxalines | 2008 |
(-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinoma; Catechin; Cholesterol; Colonic Neoplasms; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Insulin; Intestinal Mucosa; Leptin; Male; Mice; Mice, Inbred C57BL; Precancerous Conditions; Receptor, IGF Type 1; Triglycerides | 2008 |
Inhibition of catechol-Omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG.
Topics: Apoptosis; Breast Neoplasms; Carcinoma; Catechin; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cell Proliferation; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Female; Flavonoids; Humans; Phenols; Polyphenols; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Tea; Tumor Cells, Cultured | 2010 |
Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Catechin; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Humans; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Metastasis; Prostatic Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma; Caspase 3; Catechin; Cell Line; Cell Survival; Chemoprevention; Gum Arabic; Humans; Male; Nanoparticles; Polysaccharides; Prostatic Neoplasms; Tea | 2011 |
Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma; Catechin; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cyclin B1; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Signal Transduction; Thyroid Neoplasms | 2011 |
Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1α and P-gp in the human pancreatic carcinoma cell line PANC-1.
Topics: Antineoplastic Agents; Antioxidants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Catechin; Cell Line, Tumor; Cell Proliferation; Gene Expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Pancreatic Neoplasms; RNA, Messenger; Transcription, Genetic | 2012 |
Inhibitory effects of (-)-epigallocatechin-3-gallate and pterostilbene on pancreatic cancer growth in vitro.
Topics: Anticarcinogenic Agents; Carcinoma; Caspases; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytochromes c; DNA Fragmentation; Drug Evaluation, Preclinical; Humans; Pancreatic Neoplasms; Stilbenes | 2012 |
Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Camellia sinensis; Carcinoma; Catechin; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; Phytotherapy; Plant Extracts; Polyphenols; Tea | 2012 |
[Effects of EGCG on the nasopharyngeal carcinoma cell line CNE-2 and the expression of related gene].
Topics: Apoptosis; bcl-2-Associated X Protein; Carcinoma; Caspase 3; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2012 |
Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate.
Topics: Antineoplastic Agents, Phytogenic; Biocompatible Materials; Carcinoma; Catechin; Cell Division; Collagen; Cyclin D1; Drug Combinations; Humans; Laminin; Neoplasm Invasiveness; Pancreatic Neoplasms; Proteoglycans; Tea; Tumor Cells, Cultured | 2002 |
Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Carrier Proteins; Catechin; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p18; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; Enzyme Inhibitors; G1 Phase; Humans; Intracellular Signaling Peptides and Proteins; Male; Prostatic Neoplasms; Signal Transduction; Tumor Suppressor Proteins | 2003 |
A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camellia sinensis; Carcinogenicity Tests; Carcinoma; Catechin; Cell Division; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Papillomaviridae; Tumor Cells, Cultured; Tumor Virus Infections; Uterine Cervical Neoplasms | 2003 |
Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Breast Neoplasms; Carcinoma; Catechin; Cell Division; Cell Line, Tumor; Cyclin D1; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Genes, Reporter; Head and Neck Neoplasms; Humans; Immunoblotting; Luciferases; Paclitaxel; Phosphorylation; Prognosis; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Receptor, ErbB-2; Signal Transduction; Time Factors | 2003 |
Induction of apoptosis by EGCG in selected tumour cell lines in vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Catechin; Cell Line; Cell Line, Tumor; Comet Assay; Dose-Response Relationship, Drug; Humans; Neoplasms | 2003 |
Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate.
Topics: Antioxidants; Basement Membrane; Carcinoma; Catechin; Gene Expression Regulation, Neoplastic; Humans; Male; Matrix Metalloproteinase 2; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Tea; Tumor Cells, Cultured | 2004 |
Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.
Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Carcinoma; Carcinoma, Hepatocellular; Catechin; Cell Hypoxia; Culture Media; Extracellular Signal-Regulated MAP Kinases; Female; HeLa Cells; Humans; Hypoxia-Inducible Factor 1; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Plant Extracts; RNA, Messenger; Sirolimus; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2006 |
Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma.
Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma; Catechin; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Dietary Supplements; Female; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Pilot Projects; Radiation-Protective Agents; Vitamin E | 2007 |
(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; STAT3 Transcription Factor; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Camellia sinensis; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Humans; Male; Neovascularization, Pathologic; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2008 |
Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins and black tea theaflavins.
Topics: Animals; Antioxidants; Biflavonoids; Carcinoma; Catechin; Free Radical Scavengers; Gallic Acid; Lung Neoplasms; Matrix Metalloproteinase Inhibitors; Mice; Tea; Tumor Cells, Cultured | 1997 |
Green tea constituent (--)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Catechin; Cell Division; Colonic Neoplasms; DNA Topoisomerases, Type II; Enzyme Inhibitors; Humans; Tea; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2001 |